% Expired Patents = 100.0

Forward Citations = 26

Loading Chart...

5 inventors (with patents filed for the assignee):

Mehdi Gasmi (4 out of 7 patents)

Raymond T Bartus (2 out of 13 patents)

Kathie M Bishop (2 out of 2 patents)

4. Elias T Ketchum (2 out of 2 patents)

5. Dominick A Vacante (2 out of 2 patents)

4 patents: Sort by Forward Citations

1. 8420619 - Rescue of photoreceptors by intravitreal administration of an expression vector encoding a therapeutic protein (2013-04-16),

2. 8242093 - Rescue of photoreceptors by intravitreal administration of an expression vector encoding a therapeutic protein (2012-08-14),

3. 8092429 - Needle assembly for use in delivering precise dosages of proteinaceous pharmaceutical compositions and methods for use of same (2012-01-10),

4. 7837668 - Needle assembly for use in delivering precise dosages of proteinaceous pharmaceutical compositions and methods for use of same (2010-11-23),

Company Overview

Ceregene, Inc. is a biotechnology company focused on developing gene therapies for neurological disorders. The company's innovative approach involves using gene delivery technology to target specific genes associated with diseases such as Parkinson's and Alzheimer's. Ceregene's mission is to improve the lives of patients suffering from these debilitating conditions through cutting-edge research and development.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

4 Patents

#1,008 in San Diego, CA

#14,058 in California

#60,671 in US

San Diego, CA, United States of America

Ceregene, Inc.

Forward Citations = 26

5 inventors:

Mehdi Gasmi (4 out of 7 patents)

Raymond T Bartus (2 out of 13 patents)

Kathie M Bishop (2 out of 2 patents)

4. Elias T Ketchum (2 out of 2 patents)

5. Dominick A Vacante (2 out of 2 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Ceregene, Inc.. Retrieved from https://idiyas.com/company/ceregene

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]